Page last updated: 2024-08-16

sotalol and propafenone

sotalol has been researched along with propafenone in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (5.32)	18.7374
1990's	24 (25.53)	18.2507
2000's	44 (46.81)	29.6817
2010's	17 (18.09)	24.3611
2020's	4 (4.26)	2.80

Authors

Authors	Studies
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R	1
Courtney, KR; Hill, BC; Summers, RA	1
Deiwick, M; Konertz, W; Scheld, HH; Weyand, M	1
Németh, M; Papp, JG	1
Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F	1
Antman, EM; Beamer, AD; Cantillon, C; Friedman, PL; McGowan, N	1
Bauernfeind, RA; Welch, WJ	1
Hoffman, BF; Spinelli, W	1
Huang, SK; Marcus, FI	1
Allessie, MA; Bonke, FI; Lammers, WJ; Rensma, PL; Schalij, MJ	1
Camin, G; Disertori, M; Fiorentini, F; Furlanello, F; Guareneiro, M; Inama, G; Nicasi, L	1
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P	1
Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C	1
Green, MS; Kantoch, MJ; Tang, AS	1
Antman, EM; Cantillon, CO; Lamas, GA; Reimold, SC	1
Gutiérrez-Larraya, F; Jabón, A	1
Lüderitz, B; Manz, M	1
Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R	1
Bourne, GW; Nattel, S; Talajic, M; Villemaire, C; Wang, J; Wang, Z	1
Antman, EM; Cantillon, CO; Friedman, PL; Reimold, SC	1
Bellandi, F; Cantini, F; Dabizzi, RP; Niccoli, L; Palchetti, R	1
Beukema, WP; Defauw, JJ; Hoogteijling-van Dusseldorp, E; Kelder, JC; Kingma, JH; van Hemel, NM; Vermeulen, FE	1
Roden, DM	1
Briglia, N; Ducceschi, V; Esposito, R; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B; Scialdone, A	1
Chang, MS; Chen, SA; Chen, YJ; Cheng, JJ; Chiang, CE; Fong, AN; Huang, JL; Lee, SH; Tai, CT; Wen, ZC; Yu, WC	1
Burattini, M; Carunchio, A; Ceci, V; Coletta, C; Fera, MS; Galati, A; Mazza, A	1
Kuhn, RJ; Luedtke, SA; McCaffrey, FM	1
Chang, MS; Chen, SA; Chiang, CE; Ding, YA; Hsieh, MH; Tai, CT; Wen, ZC	1
Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC	1
Briglia, N; Ducceschi, V; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B	1
Connolly, S; Dorian, P; Dubuc, M; Eisenberg, MJ; Gagné, P; Green, M; Kus, T; Lambert, J; Nattel, S; Roy, D; Talajic, M; Thibault, B	1
Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL	1
Aggarwal, A	1
Couturier, A; Dorian, P; Newman, D; Paquette, M; Roy, D; Talajic, M; Yang, C	1
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K	1
Chrysostomakis, SI; Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Mavrakis, HE; Vardas, PE	1
Bellandi, F; Dabizzi, RP; Frascarelli, F; Giovannini, T; Leoncini, M; Maioli, M; Simonetti, I	1
Huang, SK; Lai, LP; Lien, WP; Lin, JL; Tseng, YZ	1
Alboni, P; Bongiorni, MG; Botto, GL; Brignole, M; Bruna, C; Gasparini, M; Menozzi, C; Ometto, R; Verlato, R; Vincenti, A	1
Connolly, SJ; Dorian, P; Green, M; Newman, D; Paquette, M; Roy, D; Talajic, M	1
Klein, G; Krahn, A; Skanes, AC; Yee, R	1
Couturier, A; Dubuc, M; Frasure-Smith, N; Gagné, P; Lambert, J; Lumer, GB; Nattel, S; Roy, D; Talajic, M; Thibault, B	1
Khairy, P; Nattel, S	1
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL	1
Jalil, E; Kus, T; Mensour, B; Vinet, A	1
Friberg, J; Gadsbøll, N	1
Hennersdorf, MG; Niebch, V; Perings, C; Strauer, BE; Vester, EG; Winter, J	1
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K	1
Lumer, G; Nattel, S; Roy, D; Talajic, M	1
Dorian, P; Mangat, I	1
Sung, RJ	1
Borbély, M; Dani, G; Erdej, F; Hajdara, I; Katona, A; Márk, L; Nagy, E; Sziklai, G	1
Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ	1
Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M	1
Chlouverakis, GI; Hamilos, ME; Igoumenidis, NE; Klapsinos, NC; Kochiadakis, GE; Tzerakis, PG; Vardas, PE	1
Block, JE; Calkins, H; Cher, D; Kocheril, AG; Sharma, AD; Stubbs, HA	1
Scharf, C	1
Ata, N; Birdane, A; Cavusoglu, Y; Goktekin, O; Gorenek, B; Kudaiberdieva, G; Timuralp, B; Unalir, A	1
Akhtar, M; Narayan, G; Sra, J	1
Fodstad, H; Kontula, K; Laitinen-Forsblom, P; Lehtonen, A; Swan, H; Toivonen, L	1
Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T	1
Boriani, G; Chiarandà, G; Colletti, A; Di Giovanni, N; Grammatico, A; Gulizia, M; Lisi, F; Mangiameli, S; Orazi, S; Pensabene, O; Piccione, G; Vasquez, L	1
Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O	1
Dabouz, F; Ducharme, A; Nattel, S; Palardy, M; Racine, N; Roy, D; Talajic, M; Tardif, JC; Tétreault, K; White, M	1
Lip, GY; Watson, T	1
Földesi, C; Kardos, A; Ladunga, K; Mihálcz, A; Szili-Török, T	1
Bednarska, D; Gilewski, W; Sinkiewicz, W	1
Breithardt, G; Camm, J; Crijns, H; Dorian, P; Kowey, PR; Le Heuzey, JY; Pedrazzini, L; Prystowsky, EN; Salette, G; Schwartz, PJ; Torp-Pedersen, C; Weintraub, W	1
Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M	1
Kong, DF; Piccini, JP	1
Apostolakis, S; Lip, GY	1
Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X	1
Kuan, TC; Kuo, CE; Liang, SF; Lin, CS; Lu, SS	1
Bouras, G; Deftereos, S; Efremidis, M; Giannopoulos, G; Kaoukis, A; Karageorgiou, S; Katsivas, A; Kossyvakis, C; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C	1
Jankovic, SM; Kostic, M; Paunovic, D; Tesic, D	1
Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L	1
Ge, H; Jiang, H; Li, X; Liu, H	1
Alexopoulos, D; Chiladakis, J; Chouchoulis, K; Davlouros, P; Kaza, M; Koutsogiannis, N	1
Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y	1
Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C	1
Bjeloševič, M; Chalupka, M; Hatala, R; Illíková, V; Olejník, P; Tomko, J	1
Kapustnick, Y; Lutsenko, R; Sуdorenko, A	1
Bukumirić, Z; Jurčević, R; Kojić, D; Marić, M; Radunović, A; Rajsic, S; Sušić, M; Tomović, M; Žugić, V	1

Reviews

18 review(s) available for sotalol and propafenone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antiarrhythmic drug therapy of ventricular arrhythmias. Current problems in cardiology, 1986, Volume: 11, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil	1986
[Long-term drug therapy of reciprocating supraventricular tachycardia: re-examination of a selected series of cases, using computerized programs]. Bollettino della Societa italiana di cardiologia, 1980, Volume: 25, Issue:10 Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Computers; Digoxin; Humans; Medigoxin; Middle Aged; Oxprenolol; Propafenone; Propiophenones; Sotalol; Tachycardia; Verapamil	1980
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol]. Annales de cardiologie et d'angeiologie, 1982, Volume: 31, Issue:7 Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide	1982
[Tachycardias: considerations in childhood in the 90s]. Anales espanoles de pediatria, 1993, Volume: 39, Issue:6 Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular	1993
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy. European heart journal, 1993, Volume: 14 Suppl E Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil	1993
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock]. Presse medicale (Paris, France : 1983), 1993, Nov-20, Volume: 22, Issue:36 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol	1993
Is there a need for new antiarrhythmic drugs? Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89 Spec No 1 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes	1996
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:10 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Child, Preschool; Digoxin; Flecainide; Humans; Infant; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome	1997
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. The American journal of cardiology, 2000, May-25, Volume: 85, Issue:10A Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil	2000
New insights into the mechanisms and management of atrial fibrillation. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002, Oct-29, Volume: 167, Issue:9 Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Humans; Practice Guidelines as Topic; Propafenone; Sotalol; Warfarin	2002
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States	2003
Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF. Cardiac electrophysiology review, 2003, Volume: 7, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; Propafenone; Sotalol	2003
Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic drugs: update on clinical trial results. Cardiac electrophysiology review, 2003, Volume: 7, Issue:3 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Humans; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome; Verapamil	2003
[Atrial flutter and fibrillation]. Praxis, 2005, Nov-09, Volume: 94, Issue:45 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents	2005
Atrial fibrillation (acute onset). BMJ clinical evidence, 2008, May-02, Volume: 2008 Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol	2008
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome	2011
Atrial fibrillation (acute onset). BMJ clinical evidence, 2011, Feb-15, Volume: 2011 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Sotalol	2011

Trials

29 trial(s) available for sotalol and propafenone

Article	Year
Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia. Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bundle-Branch Block; Cardiac Pacing, Artificial; Defibrillators, Implantable; Electrocardiography; Female; Forecasting; Humans; Male; Middle Aged; Pacemaker, Artificial; Probability; Propafenone; Sotalol; Tachycardia, Ventricular; Time Factors	1993
Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. American heart journal, 1995, Volume: 129, Issue:6 Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Chronic Disease; Female; Heart Atria; Heart Diseases; Heart Rate; Heart Ventricles; Humans; Life Tables; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Regression Analysis; Risk Factors; Sotalol; Stroke Volume; Treatment Failure	1995
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. The American journal of cardiology, 1993, Mar-01, Volume: 71, Issue:7 Topics: Aged; Atrial Fibrillation; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol	1993
[Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study]. Giornale italiano di cardiologia, 1996, Volume: 26, Issue:4 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Placebos; Propafenone; Sotalol; Time Factors	1996
Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia. European heart journal, 1996, Volume: 17, Issue:4 Topics: Adult; Aged; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Sotalol; Survival Analysis; Tachycardia, Ventricular; Treatment Failure	1996
Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. The American journal of cardiology, 1997, Apr-01, Volume: 79, Issue:7 Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Propafenone; Sotalol	1997
[Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence]. Giornale italiano di cardiologia, 1997, Volume: 27, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol	1997
Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias. International journal of cardiology, 1998, Mar-13, Volume: 64, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Chi-Square Distribution; Chronic Disease; Electrocardiography, Ambulatory; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Sotalol; Tilt-Table Test; Treatment Outcome; Ventricular Dysfunction, Left	1998
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. Circulation, 1998, Jun-16, Volume: 97, Issue:23 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil	1998
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. The New England journal of medicine, 2000, Mar-30, Volume: 342, Issue:13 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Female; Humans; Male; Middle Aged; Propafenone; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Sotalol	2000
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. The American journal of cardiology, 2000, Oct-01, Volume: 86, Issue:7 Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Personality; Propafenone; Quality of Life; Severity of Illness Index; Sex Factors; Sotalol; Surveys and Questionnaires	2000
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. American heart journal, 2000, Volume: 140, Issue:6 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol	2000
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing and clinical electrophysiology : PACE, 2000, Volume: 23, Issue:11 Pt 2 Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Risk Factors; Sotalol; Treatment Outcome	2000
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. The American journal of cardiology, 2001, Sep-15, Volume: 88, Issue:6 Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Italy; Longitudinal Studies; Male; Middle Aged; Propafenone; Recurrence; Sotalol; Treatment Outcome	2001
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. European heart journal, 2002, Volume: 23, Issue:11 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Echocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Pacemaker, Artificial; Propafenone; Prospective Studies; Quality of Life; Sotalol; Time Factors	2002
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. American heart journal, 2002, Volume: 143, Issue:6 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Health Status Indicators; Humans; Male; Mental Health; Propafenone; Quality of Life; Recurrence; Regression Analysis; Severity of Illness Index; Sotalol	2002
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. European heart journal, 2002, Volume: 23, Issue:13 Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Costs and Cost Analysis; Female; Humans; Male; Middle Aged; Propafenone; Sotalol	2002
Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation: a randomised comparison. Cardiology, 2003, Volume: 99, Issue:2 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Creatine Kinase; Electric Countershock; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Random Allocation; Recurrence; Severity of Illness Index; Sotalol; Time Factors; Treatment Outcome; Troponin T	2003
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. Cardiac electrophysiology review, 2003, Volume: 7, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome	2003
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. Cardiac electrophysiology review, 2003, Volume: 7, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Health Status Indicators; Humans; Propafenone; Prospective Studies; Quality of Life; Recurrence; Sotalol	2003
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. The American journal of cardiology, 2004, Dec-15, Volume: 94, Issue:12 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Safety; Sotalol	2004
Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2005, Volume: 12, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Quality of Life; Sotalol; Surveys and Questionnaires; Treatment Outcome	2005
Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis. International journal of cardiology, 2006, Jan-13, Volume: 106, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Prospective Studies; Recurrence; Sotalol	2006
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment	2007
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA American heart journal, 2008, Volume: 155, Issue:1 Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Probability; Propafenone; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Sotalol; Statistics, Nonparametric; Survival Rate; Treatment Outcome	2008
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery]. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2008, Volume: 8, Issue:3 Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Diltiazem; Female; Humans; Incidence; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Single-Blind Method; Sotalol; Treatment Outcome; Turkey	2008
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). The Canadian journal of cardiology, 2008, Volume: 24, Issue:9 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Humans; Male; Middle Aged; Multivariate Analysis; Propafenone; Prospective Studies; Renin; Renin-Angiotensin System; Secondary Prevention; Sotalol	2008
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clinical cardiology, 2010, Volume: 33, Issue:3 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Glycosides; Cardiotonic Agents; Clinical Competence; Female; Flecainide; Health Care Surveys; Health Knowledge, Attitudes, Practice; Heart Rate; Humans; Internationality; Male; Middle Aged; Practice Guidelines as Topic; Propafenone; Prospective Studies; Registries; Sotalol; Surveys and Questionnaires	2010
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients. The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Propafenone; Sotalol; Sympatholytics; Treatment Outcome	2013

Other Studies

47 other study(ies) available for sotalol and propafenone

Article	Year
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15 Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water	2001
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells. Journal of medicinal chemistry, 2021, 06-24, Volume: 64, Issue:12 Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship	2021
d-Sotalol has opposite effects from encainide and propafenone on the proportion of episodes of ventricular tachycardia that are sustained in an experimental substrate for reentry. Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:4 Topics: Animals; Encainide; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Propafenone; Rabbits; Sotalol; Tachycardia	1992
Is pretransplant antiarrhythmic drug therapy a risk factor? Transplantation proceedings, 1992, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Mexiletine; Middle Aged; Postoperative Complications; Premedication; Propafenone; Quinidine; Sotalol; Survival Rate; Transplantation, Heterotopic	1992
Effects of simulated ischaemia on the electrical activity of ventricular myocardium in the presence of antiarrhythmic drugs. Acta physiologica Hungarica, 1991, Volume: 77, Issue:3-4 Topics: Action Potentials; Animals; Coronary Disease; Electric Stimulation; Female; Heart; Heart Conduction System; Male; Membrane Potentials; Myocardial Reperfusion; Propafenone; Rabbits; Sotalol	1991
Arrhythmogenic effects of antiarrhythmic drugs. Cardiologia (Rome, Italy), 1990, Volume: 35, Issue:1 Suppl Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil	1990
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. Journal of the American College of Cardiology, 1990, Mar-01, Volume: 15, Issue:3 Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Data Interpretation, Statistical; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol	1990
New hope in atrial fibrillation. Journal of the American College of Cardiology, 1990, Mar-01, Volume: 15, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Propafenone; Quinidine; Sotalol	1990
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circulation research, 1989, Volume: 65, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol	1989
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circulation research, 1988, Volume: 62, Issue:2 Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Dogs; Female; Heart Conduction System; Lidocaine; Male; Neural Conduction; Ouabain; Physical Exertion; Propafenone; Quinidine; Refractory Period, Electrophysiological; Sotalol	1988
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect. Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil	1995
Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation, 1993, Volume: 88, Issue:3 Topics: Animals; Atrial Fibrillation; Atrial Function; Cardiac Pacing, Artificial; Dogs; Electric Stimulation; Female; Heart Conduction System; Male; Procainamide; Propafenone; Sotalol; Vagus Nerve	1993
[Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy]. Cardiologia (Rome, Italy), 1996, Volume: 41, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Sotalol; Ventricular Function	1996
Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. International journal of cardiology, 1998, Sep-30, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Sotalol; Ventricular Function	1998
Amiodarone to prevent recurrence of atrial fibrillation. The New England journal of medicine, 2000, Aug-24, Volume: 343, Issue:8 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Humans; Hypertrophy, Left Ventricular; Propafenone; Secondary Prevention; Sotalol	2000
Global distribution of atrial ectopic foci triggering recurrence of atrial tachyarrhythmia after electrical cardioversion of long-standing atrial fibrillation: a bi-atrial basket mapping study. Journal of the American College of Cardiology, 2001, Mar-01, Volume: 37, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol; Tachycardia, Ectopic Atrial	2001
Amiodarone: pearl or peril? European heart journal, 2002, Volume: 23, Issue:13 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Humans; Propafenone; Sotalol	2002
Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter. The Canadian journal of cardiology, 2003, Mar-15, Volume: 19, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Research Design; Sotalol; Treatment Outcome	2003
Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy. Cardiology, 2003, Volume: 99, Issue:4 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Heart Arrest; Humans; Male; Mexiletine; Middle Aged; Prognosis; Propafenone; Sotalol; Survivors; Time Factors; Treatment Outcome	2003
Atrial fibrillation: rate control often better than rhythm control. Prescrire international, 2004, Volume: 13, Issue:70 Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States	2004
[Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. Orvosi hetilap, 2004, May-09, Volume: 145, Issue:19 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology Service, Hospital; Electric Countershock; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Male; Middle Aged; Prajmaline; Propafenone; Quinidine; Retrospective Studies; Sotalol	2004
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs. Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:7 Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function	2004
Limitations to antiarrhythmic drug use in patients with atrial fibrillation. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Sep-28, Volume: 171, Issue:7 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol	2004
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2006, Volume: 15, Issue:3 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female; Flecainide; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Secondary Prevention; Sotalol; Sulfonamides; Treatment Failure; Treatment Outcome	2006
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart rhythm, 2007, Volume: 4, Issue:5 Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Finland; Flecainide; Founder Effect; Genetic Predisposition to Disease; Genetic Testing; Heart Conduction System; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Middle Aged; Mutation; Propafenone; Risk Factors; Sotalol; Torsades de Pointes; Treatment Outcome	2007
[Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation]. Orvosi hetilap, 2009, Sep-06, Volume: 150, Issue:36 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Catheter Ablation; Drug Administration Schedule; Female; Follow-Up Studies; Heart Atria; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Propafenone; Pulmonary Veins; Research Design; Sample Size; Sotalol; Tachycardia, Supraventricular; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2009
[Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol]. Kardiologia polska, 2009, Volume: 67, Issue:8 Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Propafenone; Respiratory Tract Infections; Shock, Cardiogenic; Sotalol; Tachycardia, Ventricular; Virus Diseases	2009
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement? Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome	2011
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs]. Medicina clinica, 2013, Apr-20, Volume: 140, Issue:8 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabetes Mellitus; Female; Flecainide; Heart Rate; Heart Valve Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Propafenone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Remission Induction; Sotalol; Time Factors; Treatment Outcome	2013
Estimation and prediction of drug therapy on the termination of atrial fibrillation by autoregressive model with exogenous inputs. IEEE journal of biomedical and health informatics, 2013, Volume: 17, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Computer Simulation; Female; Heart Conduction System; Propafenone; Signal Processing, Computer-Assisted; Sotalol; Swine	2013
Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia. Kardiologia polska, 2015, Volume: 73, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Disease-Free Survival; Humans; Models, Theoretical; Propafenone; Serbia; Sotalol	2015
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. The American journal of cardiology, 2015, Feb-01, Volume: 115, Issue:3 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol	2015
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children. Pediatric cardiology, 2017, Volume: 38, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Male; Metoprolol; Multivariate Analysis; Propafenone; Retrospective Studies; Sotalol; Tachycardia, Ectopic Atrial; Treatment Outcome	2017
Impact of QT interval prolongation following antiarrhythmic drug therapy on left ventricular function. Future cardiology, 2017, Volume: 13, Issue:1 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Propafenone; Sotalol; Ventricular Function, Left	2017
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. The American journal of cardiology, 2017, 05-01, Volume: 119, Issue:9 Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Propafenone; Sotalol; Tachycardia; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ectopic Atrial; Tachycardia, Ventricular; Time Factors; Treatment Outcome	2017
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics. Clinical therapeutics, 2018, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol	2018
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study. Pacing and clinical electrophysiology : PACE, 2020, Volume: 43, Issue:7 Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregnancy; Propafenone; Retrospective Studies; Slovakia; Sotalol; Tachycardia, Supraventricular	2020
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM. Georgian medical news, 2021, Issue:315 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Propafenone; Sotalol	2021
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol. Clinical cardiology, 2023, Volume: 46, Issue:10 Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Retrospective Studies; Sotalol; Ventricular Premature Complexes	2023